Aquasomes are an innovative class of nanoparticulate carrier systems with significant potential in drug delivery. These three-layered, self-assembled structures consist of a solid-phase nanocrystalline core coated with an oligomeric film, onto which bioactive molecules are adsorbed. The unique water-like properties of aquasomes protect and preserve delicate biological molecules, ensuring conformational integrity and high surface exposure. This characteristic makes them particularly effective in delivering proteins, peptides, genes, and vaccines to specific locations within the body. The core materials, such as calcium phosphate, nanocrystalline carbon ceramics, and tin oxide, support the stability and bioactivity of the loaded drugs. Aquasomes are assembled through non-covalent and ionic bonding, and their structural stability is maintained by interactions among charged groups, hydrogen bonding, and van der Waals forces. These nanoparticles offer a promising delivery solution for drugs facing challenges like chemical instability, low absorption, and significant side effects. Applications of aquasomes in protein and peptide delivery, gene therapy, vaccine delivery, and cancer therapy have demonstrated their versatility and efficiency. Despite their potential, challenges such as controlled drug release and specific targeting need further exploration. Overall, aquasomes represent a fusion of principles from food chemistry, biophysics, and microbiology, offering a robust platform for the targeted and effective delivery of various bioactive molecules.
Read full abstract